TGFB1 and neoplasm: Meanwhile, the TGF-β signaling pathway not only promotes cancer cell invasion and dissemination but also creates an immune suppressive environment by shaping the tumor’s structure and inhibiting the anti-tumor activity of immune cells, thereby impeding or weakening immune-based cancer therapies [41].